These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6402795)
1. GABA-ergic drugs: effects on conditioning, memory and learning. Rayevsky KS; Kharlamov AN Pharmacol Res Commun; 1983 Jan; 15(1):85-96. PubMed ID: 6402795 [TBL] [Abstract][Full Text] [Related]
2. [Neurochemical aspects of the pharmacology of GABAergic substances]. Raevskiĭ KS Farmakol Toksikol; 1981; 44(5):517-29. PubMed ID: 6273211 [No Abstract] [Full Text] [Related]
3. [Tranquilizing effect of n-dipropylacetate and other GABA-ergic substances in conflict situations]. Kharlamov AN; Raevskiĭ KS Biull Eksp Biol Med; 1980 Jul; 89(7):35-7. PubMed ID: 6773597 [TBL] [Abstract][Full Text] [Related]
4. The role of GABA in the anticonflict action of sodium valproate and chlordiazepoxide. Vellucci SV; Webster RA Pharmacol Biochem Behav; 1984 Dec; 21(6):845-51. PubMed ID: 6151667 [TBL] [Abstract][Full Text] [Related]
5. Di-n-propylacetate-induced abstinence behaviour as a possible correlate of increased GABA-ergic activity in the rat. de Boer T; Bartels K; Metselaar HJ; Bruinvels J Psychopharmacology (Berl); 1980; 71(3):257-67. PubMed ID: 6779333 [TBL] [Abstract][Full Text] [Related]
6. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy. Markovska V; Georgiev V Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612 [TBL] [Abstract][Full Text] [Related]
7. [Piracetam correction of deficient GABA-ergic inhibition due to early postnatal exposure to cycloheximide]. Burov IuV; Ostrovskaia RU; Smol'nikova NM; Trofimov SS; Molodavkin GM Biull Eksp Biol Med; 1986 Apr; 101(4):447-9. PubMed ID: 3008881 [TBL] [Abstract][Full Text] [Related]
8. Valproate enhances GABA turnover in the substantia nigra. Löscher W Brain Res; 1989 Oct; 501(1):198-203. PubMed ID: 2508993 [TBL] [Abstract][Full Text] [Related]
9. Quasi-morphine withdrawal behaviour: indication for a specific involvement of the GABA-ergic nerve terminal compartment. van der Laan JW Life Sci; 1983; 33 Suppl 1():389-92. PubMed ID: 6420629 [TBL] [Abstract][Full Text] [Related]
10. GABAergic modulation of memory with regard to passive avoidance and conditioned suppression task in mice. Nabeshima T; Noda Y; Kameyama T Psychopharmacology (Berl); 1988; 94(1):69-73. PubMed ID: 3126529 [TBL] [Abstract][Full Text] [Related]
11. [Effects of cerebral GABA level on learning and memory]. Zhang SS; Zhu TJ; Zhang DS; Chen XY Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):10-2. PubMed ID: 2816394 [TBL] [Abstract][Full Text] [Related]
12. GABA involvement in memory consolidation: evidence from posttrial amino-oxyacetic acid. Katz RJ; Liebler L Psychopharmacology (Berl); 1978 Mar; 56(2):191-3. PubMed ID: 417370 [TBL] [Abstract][Full Text] [Related]
13. GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures. Corbett R; Fielding S; Cornfeldt M; Dunn RW Psychopharmacology (Berl); 1991; 104(3):312-6. PubMed ID: 1681557 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration. Sethy VH Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Löscher W; Hörstermann D Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305 [TBL] [Abstract][Full Text] [Related]
16. GABA and the behavioral effects of anxiolytic drugs. Sanger DJ Life Sci; 1985 Apr; 36(16):1503-13. PubMed ID: 2858804 [TBL] [Abstract][Full Text] [Related]
17. Effects of carbamazepine, valproate calcium, clonazepam and piracetam on behavioral test methods for evaluation of memory-enhancing drugs. Rostock A; Hoffmann W; Siegemund C; Bartsch R Methods Find Exp Clin Pharmacol; 1989 Sep; 11(9):547-53. PubMed ID: 2511385 [TBL] [Abstract][Full Text] [Related]
18. GABA-ergic drugs block the locomotor stimulant effects of 1,3-dimethyl-5-aminoadamantane (D-145). Menon MK; Clark WG Neuropharmacology; 1979 Feb; 18(2):223-5. PubMed ID: 431791 [No Abstract] [Full Text] [Related]
19. [Comparative study of the effect of picamilone and piracetam on learning in rats in a radial maze]. Voznesenskiĭ AG; Kovalev GV; Sazhin VA Farmakol Toksikol; 1989; 52(4):14-7. PubMed ID: 2806520 [TBL] [Abstract][Full Text] [Related]
20. Valproate enhances GABA-A mediated inhibition of locus coeruleus neurones in vitro. Olpe HR; Steinmann MW; Pozza MF; Brugger F; Schmutz M Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):655-7. PubMed ID: 2854215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]